BayWa's Restructuring Plan Faces Mounting Challenges

BayWa faces a €2.7B funding gap in its €4B restructuring. US subsidy cuts cripple its renewable unit, forcing job cuts and a withdrawn forecast, while legal probes intensify.

The German conglomerate BayWa is navigating a complex and multi-faceted restructuring, with recent developments casting doubt on the feasibility of its four-billion-euro stabilization target. While asset sales are a cornerstone of the plan, the process is proving difficult.

Asset Sale Complications and a Funding Gap

A significant move involves the potential divestment of its New Zealand-based fruit trading subsidiary, T&G Global. The company has officially mandated Goldman Sachs to manage the sale process. However, the anticipated proceeds of approximately 300 million euros represent only a fraction of the total capital required. To date, BayWa has secured just 1.3 billion euros of its four-billion-euro goal, leaving a substantial shortfall.

The T&G Global sale faces its own hurdles. Minority shareholder Joy Wing Mau Group, which holds nearly 20% of T&G, is complicating the proceedings. T&G Global itself has stated that a final decision regarding a sale has not yet been reached.

U.S. Policy Shift Undermines Renewable Energy Unit

Concurrently, BayWa's renewable energy subsidiary, BayWa r.e., is confronting a major setback in a key market. The passage of the "One Big Beautiful Bill Act" in the United States has significantly reduced subsidies for renewable energy projects. This is particularly damaging as the U.S. is the company's most important sales region, having seen over 530 megawatts of project capacity sold there in 2024. The removal of government support diminishes the attractiveness of these projects to potential buyers, threatening to create a substantial valuation gap on the balance sheet.

The repercussions are already being felt. The company has withdrawn its annual forecast for 2026 and has lowered its adjusted EBITDA target for 2027 to around 140 million euros. As part of this consolidation, BayWa r.e. plans to cut 1,300 jobs and permanently close 26 branch offices by 2027.

Legal and Governance Scrutiny Intensifies

Beyond operational restructuring, BayWa is grappling with heightened legal and auditing scrutiny. The supervisory board has tightened internal controls, lowering the approval threshold for business transactions from 200 million to 50 million euros. Meanwhile, the Munich I public prosecutor's office is conducting an investigation into former executives, including ex-CEO Marcus Pöllinger, on suspicion of breach of trust. The presumption of innocence applies to all parties involved.

The company's auditing process has also come under fire. For the 2023 financial year, PwC issued an unqualified audit opinion without highlighting going-concern risks, which included conditions attached to a billion-euro loan and refinancing risks for a 500-million-euro bond. German financial watchdog BaFin and the audit oversight body Apas have initiated related proceedings. In response, BayWa will put its audit mandate out to tender starting in 2026, and the management board is examining potential claims for damages against PwC. Furthermore, the law firm TILP is preparing lawsuits on behalf of shareholders who invested between early 2022 and January 2026.

Investor Uncertainty and a Critical Deadline

For investors, assessing the company's health has become exceptionally challenging. The publication of the consolidated financial statements for 2025 has been postponed to the fourth quarter of 2026, making a reliable evaluation of the corporate situation nearly impossible until then.

The entire restructuring framework hinges on a formal condition: the standstill agreement with core banks must be extended by autumn 2026. Without this consent, the restructuring concept loses its legal foundation. Consequently, the outcome of the T&G Global sale is far more than a simple portfolio adjustment. It serves as the first genuine stress test for the viability of BayWa's broader recovery plan.